- Home
- CSBR vs SPAI Comparison
CSBR vs SPAI Comparison
Compare CSBR & SPAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CSBR | SPAI |
|---|---|---|
| Founded | 1985 | 2021 |
| Country | | |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Industrial Specialties |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 91.0M | 87.0M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | CSBR | SPAI |
|---|---|---|
| Price | $6.03 | $4.02 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 3 |
| Target Price | ★ $12.00 | $10.00 |
| AVG Volume (30 Days) | 6.2K | ★ 185.2K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $4.84 | N/A |
| Revenue Next Year | $11.51 | $1,271.62 |
| P/E Ratio | $33.52 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $5.59 | $1.47 |
| 52 Week High | $11.16 | $9.16 |
Technical Indicators
Market Signals| Indicator | CSBR | SPAI |
|---|---|---|
| Relative Strength Index (RSI) | 36.31 | 37.20 |
| Support Level | $6.53 | $3.95 |
| Resistance Level | $6.34 | $4.65 |
| Average True Range (ATR) | 0.39 | 0.51 |
| MACD | -0.13 | -0.14 |
| Stochastic Oscillator | 6.07 | 9.64 |
Price Performance
Historical ComparisonAbout CSBR Champions Oncology Inc.
Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor-specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. The company's revenue is majorly derived from research services.
About SPAI Safe Pro Group Inc.
Safe Pro Group Inc operates to acquire security and protection products. Its emphasis is on the development of a cloud-based ecosystem for analyzing drone imagery and data utilizing proprietary artificial intelligence (AI), machine learning, deep learning, and applied computer vision software for hyper-scalable processing, analysis, and reporting. The company operated in three reportable business segments which consisted of: the business of Safe-Pro USA, the business of Airborne Response, and the business of Safe Pro AI. Key revenue is generated from Airborne Response.